NCT02921022 2025-11-26
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
Clinical Trials
5 trialsNCT04894643 2025-05-08
PARC
EBG MedAustron GmbH
Phase NA Recruiting
NCT03690323 2018-10-01
PELICAN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Unknown
NCT03443921 2018-02-23
Divestment for Artery-involved Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT01442974 2013-03-13
Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer
Grupo Hospital de Madrid
Phase NA Completed